SANTOLLA, Maria Francesca
 Distribuzione geografica
Continente #
NA - Nord America 888
EU - Europa 798
AS - Asia 90
AF - Africa 39
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
SA - Sud America 2
Totale 1823
Nazione #
US - Stati Uniti d'America 870
UA - Ucraina 283
DE - Germania 142
AT - Austria 132
IT - Italia 127
SE - Svezia 80
SN - Senegal 38
TR - Turchia 38
CN - Cina 35
CA - Canada 18
BE - Belgio 14
IN - India 12
GB - Regno Unito 7
FI - Finlandia 6
AU - Australia 4
FR - Francia 3
HK - Hong Kong 3
CH - Svizzera 2
EC - Ecuador 2
EU - Europa 2
NL - Olanda 2
SA - Arabia Saudita 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 1823
Città #
Chandler 255
Jacksonville 163
San Mateo 111
Vienna 99
Dearborn 90
Rende 59
Dakar 38
Lawrence 38
Roxbury 37
Izmir 33
Brooklyn 27
Des Moines 24
Ann Arbor 21
Ottawa 15
Brussels 14
Redmond 14
Bremen 12
Beijing 11
Wilmington 10
Inglewood 8
San Francisco 8
Cambridge 7
Como 7
Helsinki 6
Redwood City 6
Boardman 5
Berlin 4
Grafing 4
Jinan 4
Nanjing 4
Mascalucia 3
Portoferraio 3
Toronto 3
Amsterdam 2
Boydton 2
Central 2
Changsha 2
Chennai 2
Edinburgh 2
Gazi 2
Geneve 2
Genoa 2
Guayaquil 2
Haikou 2
Houston 2
Kunming 2
Melbourne 2
Paternò 2
Roggiano Gravina 2
Canberra 1
Guangzhou 1
Hangzhou 1
Hebei 1
Hefei 1
Huzhou 1
Innsbruck 1
Jiaxing 1
Johannesburg 1
Lanzhou 1
Lodi 1
Miami 1
Montalto Uffugo 1
Napoli 1
Norwalk 1
Padova 1
Palermo 1
Paris 1
Princeton 1
Riyadh 1
Sanayi 1
Seelze 1
Stillwater 1
Sydney 1
Taizhou 1
Varedo 1
Varese 1
Viareggio 1
Zhengzhou 1
Totale 1204
Nome #
(6-Bromo-1,4-dimethyl-9H-carbazol-3-yl-methylene)-hydrazine (Carbhydraz) Acts as a GPER Agonist in Breast Cancer Cells 93
GPER Mediates a Feedforward FGF2/FGFR1 Paracrine Activation Coupling CAFs to Cancer Cells Toward Breast Tumor Progression 89
Focal adhesion kinase (FAK) activation by estrogens involves GPER in triple-negative breast cancer cells 84
Estrogenic GPER signaling regulates mir144 expression in cancer cells and cancer-associated fibroblasts (CAFs) 70
Bisphenol A Induces Gene Expression Changes and Proliferative Effects through GPER in Breast Cancer Cells and Cancer-Associated Fibroblasts 70
Carbazole derivatives as potential novel agonist of GPER 64
GPER, IGF-IR, and EGFR transduction signaling are involved in stimulatory effects of zinc in breast cancer cells and cancer-associated fibroblasts 64
Copper activates HIF-1α/GPER/VEGF signalling in cancer cells 63
miR-221 stimulates breast cancer cells and cancer-associated fibroblasts (CAFs) through selective interference with the A20/c-Rel/CTGF signaling 62
Identification of two benzopyrroloxazines acting as selective GPER antagonists in breast cancer cells and cancer-associated fibroblasts 57
miR-338-3p Is Regulated by Estrogens through GPER in Breast Cancer Cells and Cancer-Associated Fibroblasts (CAFs) 57
Apoptosis of breast cancer cells induced by lauric acid occours through p21Cip/WAF1 in a p53 independent manner 55
Nuovi ligandi di recettori estrogenici accoppiati a proteina G 54
BCL11A interacts with SOX2 to control the expression of epigenetic regulators in lung squamous carcinoma 54
SIRT1 is involved in oncogenic signaling mediated by GPER in breast cancer 51
Estrogenic Gper-signaling triggers RERG expression in breast cancer cells and cancer-associated fibroblasts 51
A calixpyrrole derivative acts as an antagonist to GPER, a G-protein coupled receptor: mechanisms and models. 51
Recent Advances in the Rationale Design of GPER Ligands. 49
Identification of novel estrogen-regulated microRNAs in breast tumor cells and cancer-associated fibroblasts (CAFS) 46
MIBE acts as antagonist ligand of both estrogen receptor alpha and GPER in breast cancer cells 45
G protein-coupled estrogen receptor mediates the up-regulation of fatty acid synthase induced by 17β-estradiol in cancer cells and cancer-associated fibroblasts 43
GPER is involved in the stimulatory effects of aldosterone in breast cancer cells and breast tumor-derived endothelial cells 42
A Bodipy as a luminescent probe for detection of the G protein estrogen receptor (GPER) 42
GPER mediates activation of HIF1α/VEGF signaling by estrogens 41
HIF-1α/GPER signaling mediates the expression of VEGF induced by hypoxia in breast cancer associated fibroblasts (CAFs) 41
S100A4 Is Involved in Stimulatory Effects Elicited by the FGF2/FGFR1 Signaling Pathway in Triple-Negative Breast Cancer (TNBC) Cells 41
Two Novel GPER Agonists Induce Gene Expression Changes and Growth Effects in Cancer Cells. 40
Stimulatory actions of IGF-I are mediated by IGF-IR cross-talk with GPER and DDR1 in mesothelioma and lung cancer cells 38
Oleuropeina ed idrossitirisolo attivano pathways GPER-dipendenti inducendo apoptosi in cellule tumorali mammarie SKBR3 negative per i recettori estrogenici α e β. 38
Macromolecular Modelling and Docking Simulations for the Discovery of Selective GPER Ligands. 37
Identification of two novel benzo[b]pyrrolo[1,2-d][1,4]oxazin-4-one derivatives acting as GPER antagonists 36
Insulin-like growth factor-I regulates GPER expression and function in cancer cells 34
Niacin activates the G protein estrogen receptor (GPER)-mediated signalling 34
Oleuropein and hydroxytyrosol activate GPER/ GPR30-dependent pathways leading to apoptosis of ER-negative SKBR3 breast cancer cells 33
Novel Mechanisms Involved in the Stimulatory Effects Exerted by Zinc in Breast Cancer Cells 33
Oleuropein-induced apoptosis is mediated by mitochondrial glyoxalase 2 in NSCLC a549 cells: A mechanistic inside and a possible novel nonenzymatic role for an ancient enzyme 25
The FGF/FGFR system in breast cancer: Oncogenic features and therapeutic perspectives 24
The AGEs/RAGE Transduction Signaling Prompts IL-8/CXCR1/2-Mediated Interaction between Cancer-Associated Fibroblasts (CAFs) and Breast Cancer Cells 18
Metformin counteracts stimulatory effects induced by insulin in primary breast cancer cells 16
Identification of a human estrogen receptor α tetrapeptidic fragment with dual antiproliferative and anti-nociceptive action 1
Totale 1886
Categoria #
all - tutte 5779
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5779


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201878 0000 00 067 2531
2018/2019106 0400 320 11 322331
2019/2020369 3433034 1894 3148 2263811
2020/2021317 4134238 336 1151 3032228
2021/2022497 481136 555 8127 1461114
2022/2023505 891153395 8755 310 0000
Totale 1886